HPC Biosciences Limited operates in the agriculture industry in India.
Flawless balance sheet with questionable track record.
Share Price & News
How has HPC Biosciences's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 535217 has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: Insufficient data to determine how 535217 performed against the Indian Food industry.
Return vs Market: Insufficient data to determine how 535217 performed against the Indian Market.
Price Volatility Vs. Market
How volatile is HPC Biosciences's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is HPC Biosciences undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 535217 (₹25.95) is trading above our estimate of fair value (₹1.39)
Significantly Below Fair Value: 535217 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 535217 is poor value based on its PE Ratio (747.3x) compared to the Food industry average (12.5x).
PE vs Market: 535217 is poor value based on its PE Ratio (747.3x) compared to the Indian market (12.5x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 535217's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 535217 is overvalued based on its PB Ratio (13.2x) compared to the IN Food industry average (0.9x).
How is HPC Biosciences forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Food, Beverage & Tobacco industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as HPC Biosciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine HPC Biosciences's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- HPC Biosciences competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Food, Beverage & Tobacco industry.
How has HPC Biosciences performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 535217 has high quality earnings.
Growing Profit Margin: 535217 became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: 535217's earnings have declined by -20.8% per year over the past 5 years.
Accelerating Growth: 535217 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 535217 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Food industry (20.6%).
Return on Equity
High ROE: 535217's Return on Equity (2.6%) is considered low.
How is HPC Biosciences's financial position?
Financial Position Analysis
Short Term Liabilities: 535217's short term assets (₹240.0M) exceed its short term liabilities (₹4.4M).
Long Term Liabilities: 535217 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 535217 is debt free.
Reducing Debt: 535217 has no debt compared to 5 years ago when its debt to equity ratio was 1.7%.
Debt Coverage: 535217 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 535217 has no debt, therefore coverage of interest payments is not a concern.
Inventory Level: 535217 has a low level of unsold assets or inventory.
Debt Coverage by Assets: Insufficient data to determine if 535217's debt is covered by short term assets.
What is HPC Biosciences's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 535217's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate 535217's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 535217's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 535217's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 535217's dividend in 3 years as they are not forecast to pay a notable one for the Indian market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Tarun Chauhan (38yo)
Mr. Tarun Chauhan has been a Whole-Time Director of hpc BIOSCIENCES LIMITED since October 1, 2011. Mr. Chauhan is the Promoter of hpc BIOSCIENCES LIMITED. He is responsible for day to day affairs of hpc BI ...
CEO Compensation Analysis
Compensation vs Market: Tarun's total compensation ($USD5.87K) is below average for companies of similar size in the Indian market ($USD49.62K).
Compensation vs Earnings: Tarun's compensation has been consistent with company performance over the past year.
|Whole-Time Director||no data||₹426.00k||0.058% ₹2.4m|
|CFO & Director||8.42yrs||no data||21.87% ₹905.8m|
|Additional Independent Director||4yrs||no data||no data|
|Independent Director||2yrs||no data||no data|
Experienced Board: 535217's board of directors are considered experienced (6.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
HPC Biosciences Limited's company bio, employee growth, exchange listings and data sources
- Name: HPC Biosciences Limited
- Ticker: 535217
- Exchange: BSE
- Founded: 2002
- Industry: Agricultural Products
- Sector: Food, Beverage & Tobacco
- Market Cap: ₹4.142b
- Shares outstanding: 159.60m
- Website: https://www.hpcbiosciences.com
Number of Employees
- HPC Biosciences Limited
- Pooja Complex
- Office No. 109, First Floor
- New Delhi
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|535217||BSE (Mumbai Stock Exchange)||Yes||Equity Shares||IN||INR||Mar 2013|
HPC Biosciences Limited operates in the agriculture industry in India. The company manufactures and sells wheat, rice, pulses, and vegetables. It operates orchards of mango, guava, pomegranate, and various flowers primarily roses; and farms of trees, including poplar, eucalyptus, kadam, mentha, and bamboos. HPC Biosciences Limited was incorporated in 2002 and is based in New Delhi, India.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/03/01 13:10|
|End of Day Share Price||2019/12/03 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.